Skip to content

Elizabeth D'Amico

2 papers in the library · 9 citations · publishing 2024

Papers

Sort Most recent Most cited

Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

Frontiers in Psychiatry February 16, 2024 Terence H. W. Ching, Lucia Amoroso, Calvin Bohner et al. correction

[This corrects the article DOI: 10.3389/fpsyt.2023.1278823.].

Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

Frontiers in Psychiatry January 9, 2024 Terence H. W. Ching, Lucia Amoroso, Calvin Bohner et al. 9 citations

Background To date, few randomized controlled trials of psilocybin with non-directive support exist for obsessive-compulsive disorder (OCD). Results and participant feedback from an interim analysis of an ongoing single-dose trial (NCT03356483) converged on the possibility of administering a higher fixed dose and/or more doses of psilocybin in future trials for presumably greater benefits....

DOI: 10.3389/fpsyt.2023.1278823 (opens in new tab) Psilocybin Adult psychiatry Mental health Non-directive support +6